Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 158
Selected: 0
NCT IDTitle
NCT03387241Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years
NCT03967327A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain
NCT00995800Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
NCT01019265A Study Comparing Norspan Patch and Oral Tramadol
NCT01099722Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma
NCT01014559Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients
NCT02089581A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication
NCT03062644Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2.
NCT02013362Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
NCT01423032Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
NCT00412152Oxycodone-naloxone in Relieving Opioid-related Constipation
NCT03349333A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL
NCT01710917A Non-interventional, Observational Study for Quality of Life (Overall Health Assessment) in Patients With Chronic Severe Pain During Targinact® Treatment
NCT03789630Continuous Monitoring of Physiology and Self-reported Pain Score Amongst Post-surgical Knee Patients
NCT02160067A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches
NCT02256202Quality Assurance of Electronic Data Capturing (EDC) in Pain Treatment
NCT00801216High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement
NCT01918098Targin for Non-cancer Pain
NCT03403504OTR Tablet 10 mg Fasted-state Bioequivalence Study
NCT01675531A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
NCT01719757PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain
NCT01439100A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain
NCT01141465Real-world Effectiveness of Combination Therapy in Asthma
NCT00412100Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation
NCT01276431Norspan Efficacy and Safety Among Elderly Subjects
NCT02268422Bioequivalence and Adhesion Comparison of Buprenorphine Patches
NCT02237261Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma
NCT02063139Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.
NCT02094560CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
NCT02133820A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.
NCT01313780A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients
NCT01558167A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia
NCT03187210Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas
NCT01776411Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients
NCT02753712A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma
NCT02773316Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution
NCT01811186An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)
NCT00944697A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy
NCT00740415Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma
NCT01675635OxyNorm Capsules in Post-Operative Pain Study
NCT02321397To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT04053608Human Physiology and Self-Reported Pain Score
NCT01438567A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
NCT03768466Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment
NCT02543034Compare of Petrolatum Gauze, Allevyn, and New Dressing, Betafoam® in the Management of Split-Thickness Skin Graft Donor Site
NCT02403713A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers
NCT02195375Flutiform® Compared With Seretide® in the Treatment of COPD
NCT02446561A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication
NCT03975010Buprenorphine Transdermal Patches Pharmacokinetic Study
NCT01167699Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain